A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

NCT03017404 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Doxorubicin Hydrochloride Liposome Injection
DRUG: Cyclophosphamide
DRUG: docetaxel

Sponsor

Hebei Medical University Fourth Hospital